Keine Story von Joint source of Boehringer Ingelheim GmbH and Pfizer Inc mehr verpassen.

Joint source of Boehringer Ingelheim GmbH and Pfizer Inc

28.08.2009 – 01:06

Data From Largest GOLD Stage II Patient Population Treated With Tiotropium Highlight the Benefits of Earlier Treatment of COPD

Ingelheim, Germany (ots/PRNewswire) - - New UPLIFT(R) Analysis Shows Tiotropium Significantly Improves Lung Function and Quality of Life in COPD Patients With Early Stage Disease - Not for US Media A new analysis of the landmark UPLIFT(R) trial, published today in the Lancet, shows that tiotropium ...

mehr

1